肝機能不全(Hepatic Insufficiency):世界の治験レビュー(2015年上半期版)

【英語タイトル】Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2642CTIDB)・商品コード:GDHC2642CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年4月27日
・ページ数:75
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥802,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における肝機能不全(Hepatic Insufficiency) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 肝機能不全(Hepatic Insufficiency)
  - 当レポートの概要
・肝機能不全(Hepatic Insufficiency):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2015″ provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatic Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hepatic Insufficiency 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Puma Biotechnology, Inc. 34
Clinical Trial Overview of Puma Biotechnology, Inc. 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
C. H. Boehringer Sohn AG & Co. KG 37
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Top Institutes / Government 41
Copenhagen University Hospital Gentofte 41
Clinical Trial Overview of Copenhagen University Hospital Gentofte 41
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Aarhus University 43
Clinical Trial Overview of Aarhus University 43
Donau-Universitat Krems 44
Clinical Trial Overview of Donau-Universitat Krems 44
Huashan Hospital 45
Clinical Trial Overview of Huashan Hospital 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
McGill University Health Center 47
Clinical Trial Overview of McGill University Health Center 47
Five Key Clinical Profiles 48
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Hepatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 31
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 32
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 33
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Puma Biotechnology, Inc., 2015* 34
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 35
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 36
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 37
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 39
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe Ltd., 2015* 40
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2015* 41
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 42
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 43
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Donau-Universitat Krems, 2015* 44
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2015* 45
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 46
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 47

List of Figures
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 74

【レポートのキーワード】

肝機能不全(Hepatic Insufficiency)、治験、臨床試験、治験、治療薬

★調査レポート[肝機能不全(Hepatic Insufficiency):世界の治験レビュー(2015年上半期版)] (コード:GDHC2642CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[肝機能不全(Hepatic Insufficiency):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆